Dermata Therapeutics Inc expected to post a loss of 78 cents a share - Earnings Preview

Dermata Therapeutics

26/02/2024 23:56

* Dermata Therapeutics Inc  DRMA.OQ   DRMA.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 28 (estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Dermata Therapeutics Inc
is
for a loss of 78 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Dermata
Therapeutics Inc is $2.50​, above​ its last closing price
of $0.45. ​​​

This summary was machine generated February 26 at 23:55 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)